Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules Read more
Morgan Stanley starts Dyne Therapeutics stock with Overweight, bullish on FORCE platform By Investing.com Read more
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels By Reuters Read more